Prescription drug Published: RCT evidence Extensive real-world use

Sulfonylureas: dosing, timing and what to expect

Older diabetes drugs that force insulin release regardless of blood sugar — which is why, unlike metformin, they CAN cause hypoglycemia on their own, and reliably do when a GLP-1-class drug is added on top.

Also known as glipizide, glyburide, glimepiride, gliclazide, Diamicron, Amaryl

Educational research reference Prescription Medications

Quick reference. Everything you need to run Sulfonylureas — dosing, frequency, reconstitution math for the vial sizes people actually buy, and what it stacks with. For anything specific to your situation, ask the Guru.

Sulfonylureas quick start

Route: Oral
Typical dose: Physician-set
Frequency: Daily
Half-life: Agent-dependent, hours to a day.
Cycle: Continuous under physician supervision.

These are the numbers people actually run, drawn from the published record and from what the community has settled on over time. Educational reference, not medical advice — a starting point to work from, and one you can adjust as you learn how you respond.

How to run it

How often: Daily
Cycle length: Continuous under physician supervision.
Half-life: Agent-dependent, hours to a day.
Route: Oral

Consistency matters more than perfect timing. Pick a slot in your day you will actually keep, and let DoseIQ handle the rest.

What to expect

Most people tolerate Sulfonylureas well. Here is what is worth knowing going in, so nothing catches you by surprise.

The label-level interaction is real across the GLP-1 class: prescribers usually reduce or stop the sulfonylurea when semaglutide, tirzepatide or retatrutide starts. If yours didn't come up, ask.

Known interactions

Interactions involving Sulfonylureas's drug class that DoseIQ screens for. Each one cites where it comes from — an FDA label section or the published record — because an interaction warning you can't trace is just noise.

Serious GLP-1-class + sulfonylureas — hypoglycemia risk

Sulfonylureas force insulin release regardless of glucose; adding any GLP-1-class drug on top is the classic hypoglycemia setup.

What to do: The sulfonylurea dose is usually reduced or stopped when a GLP-1-class drug starts — ask your prescriber if that conversation hasn't happened.

Source: FDA labels, semaglutide/tirzepatide §7

Serious IGF-1 + diabetes medication — severe hypoglycemia risk

IGF-1 drives glucose into muscle on top of medication doing the same — this is the combination that puts people on the floor.

What to do: This pairing needs your prescriber's explicit awareness, glucose on hand, and monitoring.

Source: Community consensus + IGF-1 pharmacology; the Guru's straight-talk list

Caution GH peptides push blood sugar against your diabetes medication

Growth hormone raises glucose and insulin resistance — it works directly against glucose-lowering medication.

What to do: Fasting glucose and HbA1c are worth tracking; medication doses sometimes need adjusting. Your prescriber should know GH peptides are in the picture.

Source: GH pharmacology; tesamorelin label §7

Caution Corticosteroids raise blood sugar against your diabetes medication

Even short prednisone courses raise glucose; diabetes control commonly loosens during a course.

What to do: Monitor glucose during the course; prescribers often adjust doses temporarily.

Source: FDA label, prednisone §7

Caution Beta-blockers mask hypoglycemia warning signs

The racing heart that warns of a low is exactly what a beta-blocker suppresses — lows sneak up quietly.

What to do: Anyone on this combination should know sweating remains a reliable warning sign when the heart rate isn't.

Source: FDA label, metoprolol §7

DoseIQ screens your whole protocol against these rules automatically — every compound, prescription and supplement you track, cross-checked as you add them. Serious flags are always free.

Preparing it

Sulfonylureas does not need reconstituting — it comes ready to use.

Track this in DoseIQ Browse all compounds

This page is an educational research reference and is not medical advice. Dose figures reflect the published record and what the community has converged on — starting points to weigh, not instructions. Consult a qualified healthcare provider before starting any protocol.